Thomas Sciascia
Founder at TREVI THERAPEUTICS, INC.
Net worth: 706 067 $ as of 2024-03-30
Profile
Thomas R.
Sciascia is the founder and the Chief Science Officer at Trevi Therapeutics, Inc., a company founded in 2011.
He previously worked as a Medical Director at Quintiles, Inc. (California) from 1997 to 2000, and at Transkaryotic Therapies, Inc. from 2000 to 2001.
He also served as the Chief Medical Officer & Senior Vice President at Penwest Pharmaceuticals Co. from 2001 to 2010.
Prior to his industry experience, he was a Faculty Member at Boston University from 1983 to 1997.
Dr. Sciascia holds a doctorate degree from The Trustees of Columbia University in The City of New York, conferred in 1979, and an undergraduate degree from Massachusetts Institute of Technology, conferred in 1975.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TREVI THERAPEUTICS, INC.
0.30% | 2024-02-14 | 204,657 ( 0.30% ) | 706 067 $ | 2024-03-30 |
Thomas Sciascia active positions
| Companies | Position | Start |
|---|---|---|
| TREVI THERAPEUTICS, INC. | Founder | 2010-12-31 |
Former positions of Thomas Sciascia
| Companies | Position | End |
|---|---|---|
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2000-12-31 |
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 1999-12-31 |
| Boston University | Corporate Officer/Principal | 1996-12-31 |
Penwest Pharmaceuticals Co.
 Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Chief Tech/Sci/R&D Officer | - |
Training of Thomas Sciascia
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | Commercial Services |
Penwest Pharmaceuticals Co.
Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
- Stock Market
- Insiders
- Thomas Sciascia
